Effectiveness of Spacer Devices on Preventing Undesirable Cardiovascular Effects of Inhaled Salbutamol

Background: Currently, there are no regulatory guidelines indicating spacer devices/valved holding chamber (VHC) should be used routinely during pulmonary function tests, and few studies evaluated if spacer devices reduce beta-agonist bronchodilators' side effects. Methods: A prospective study...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of aerosol medicine 2021-08, Vol.34 (4), p.217-222
Hauptverfasser:	Gomes, Juliana Teixeira, Gregorio, Paulo Henrique Peitl, Santos, Ellen Samara, Ribeiro, Bruna Patricia, Gregório, Marcelo Gervilla
Format:	Artikel
Sprache:	eng
Schlagworte:	Agonists Blood pressure Bronchodilation Bronchodilators Cardiovascular diseases Health technology assessment Heart rate Inhalation Patients Respiratory function Salbutamol Spirometry Tachycardia Variation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!